Cargando…
OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review
PURPOSE: Medical staging, surgical planning, and therapeutic decisions are significantly different for brain metastases versus gliomas. Machine learning (ML) algorithms have been developed to differentiate these pathologies. We performed a systematic review to characterize ML methods and to evaluate...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351249/ http://dx.doi.org/10.1093/noajnl/vdab071.067 |
_version_ | 1783735933567238144 |
---|---|
author | Brim, Waverly Rose Jekel, Leon Petersen, Gabriel Cassinelli Subramanian, Harry Zeevi, Tal Payabvash, Sam Bousabarah, Khaled Lin, MingDe Cui, Jin Brackett, Alexandria Mahajan, Ajay Johnson, Michele Mahajan, Amit Aboian, Mariam |
author_facet | Brim, Waverly Rose Jekel, Leon Petersen, Gabriel Cassinelli Subramanian, Harry Zeevi, Tal Payabvash, Sam Bousabarah, Khaled Lin, MingDe Cui, Jin Brackett, Alexandria Mahajan, Ajay Johnson, Michele Mahajan, Amit Aboian, Mariam |
author_sort | Brim, Waverly Rose |
collection | PubMed |
description | PURPOSE: Medical staging, surgical planning, and therapeutic decisions are significantly different for brain metastases versus gliomas. Machine learning (ML) algorithms have been developed to differentiate these pathologies. We performed a systematic review to characterize ML methods and to evaluate their accuracy. METHODS: Studies on the application of machine learning in neuro-oncology were searched in Ovid Embase, Ovid MEDLINE, Cochrane trials (CENTRAL) and Web of science core-collection. A search strategy was designed in compliance with a clinical librarian and confirmed by a second librarian. The search strategy comprised of controlled vocabulary including artificial intelligence, machine learning, deep learning, magnetic resonance imaging, and glioma. The initial search was performed in October 2020 and then updated in February 2021. Candidate articles were screened in Covidence by at least two reviewers each. A bias analysis was conducted in agreement with TRIPOD, a bias assessment tool similar to CLAIM. RESULTS: Twenty-nine articles were used for data extraction. Four articles specified model development for solitary brain metastases. Classical ML (cML) algorithms represented 85% of models used, while deep learning (DL) accounted for 15%. cML algorithms performed with an average accuracy, sensitivity, and specificity of 82%, 78%, 88%, respectively; DL performed 84%, 79%, 81%. The support vector machine (SVM) algorithm was the most common used cML model in the literature and convolutional neural networks (CNN) were standard for DL models. We also found T1, T1 post-gadolinium and T2 sequences were most commonly used for feature extraction. Preliminary TRIPOD analysis yielded an average score of 14.25 (range 8–18). CONCLUSION: ML algorithms that can accurately classify glioma from brain metastases have been developed. SVM and CNN are leading approaches with high accuracy. Standardized algorithm performance reporting is a clear limitation to be addressed in future studies. |
format | Online Article Text |
id | pubmed-8351249 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-83512492021-08-09 OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review Brim, Waverly Rose Jekel, Leon Petersen, Gabriel Cassinelli Subramanian, Harry Zeevi, Tal Payabvash, Sam Bousabarah, Khaled Lin, MingDe Cui, Jin Brackett, Alexandria Mahajan, Ajay Johnson, Michele Mahajan, Amit Aboian, Mariam Neurooncol Adv Supplement Abstracts PURPOSE: Medical staging, surgical planning, and therapeutic decisions are significantly different for brain metastases versus gliomas. Machine learning (ML) algorithms have been developed to differentiate these pathologies. We performed a systematic review to characterize ML methods and to evaluate their accuracy. METHODS: Studies on the application of machine learning in neuro-oncology were searched in Ovid Embase, Ovid MEDLINE, Cochrane trials (CENTRAL) and Web of science core-collection. A search strategy was designed in compliance with a clinical librarian and confirmed by a second librarian. The search strategy comprised of controlled vocabulary including artificial intelligence, machine learning, deep learning, magnetic resonance imaging, and glioma. The initial search was performed in October 2020 and then updated in February 2021. Candidate articles were screened in Covidence by at least two reviewers each. A bias analysis was conducted in agreement with TRIPOD, a bias assessment tool similar to CLAIM. RESULTS: Twenty-nine articles were used for data extraction. Four articles specified model development for solitary brain metastases. Classical ML (cML) algorithms represented 85% of models used, while deep learning (DL) accounted for 15%. cML algorithms performed with an average accuracy, sensitivity, and specificity of 82%, 78%, 88%, respectively; DL performed 84%, 79%, 81%. The support vector machine (SVM) algorithm was the most common used cML model in the literature and convolutional neural networks (CNN) were standard for DL models. We also found T1, T1 post-gadolinium and T2 sequences were most commonly used for feature extraction. Preliminary TRIPOD analysis yielded an average score of 14.25 (range 8–18). CONCLUSION: ML algorithms that can accurately classify glioma from brain metastases have been developed. SVM and CNN are leading approaches with high accuracy. Standardized algorithm performance reporting is a clear limitation to be addressed in future studies. Oxford University Press 2021-08-09 /pmc/articles/PMC8351249/ http://dx.doi.org/10.1093/noajnl/vdab071.067 Text en © The Author(s) 2021. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Supplement Abstracts Brim, Waverly Rose Jekel, Leon Petersen, Gabriel Cassinelli Subramanian, Harry Zeevi, Tal Payabvash, Sam Bousabarah, Khaled Lin, MingDe Cui, Jin Brackett, Alexandria Mahajan, Ajay Johnson, Michele Mahajan, Amit Aboian, Mariam OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review |
title | OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review |
title_full | OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review |
title_fullStr | OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review |
title_full_unstemmed | OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review |
title_short | OTHR-12. The development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review |
title_sort | othr-12. the development of machine learning algorithms for the differentiation of glioma and brain metastases – a systematic review |
topic | Supplement Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351249/ http://dx.doi.org/10.1093/noajnl/vdab071.067 |
work_keys_str_mv | AT brimwaverlyrose othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT jekelleon othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT petersengabrielcassinelli othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT subramanianharry othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT zeevital othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT payabvashsam othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT bousabarahkhaled othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT linmingde othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT cuijin othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT brackettalexandria othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT mahajanajay othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT johnsonmichele othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT mahajanamit othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview AT aboianmariam othr12thedevelopmentofmachinelearningalgorithmsforthedifferentiationofgliomaandbrainmetastasesasystematicreview |